Dr. Finnegan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1236 Huffman Mill Rd
Burlington, NC 27215Phone+1 336-538-7725Fax+1 919-966-6735
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2005 - 2008
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2001 - 2004
Drexel University College of MedicineClass of 2001
Certifications & Licensure
NC State Medical License 2005 - 2025
VA State Medical License 2001 - 2006- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Publications & Presentations
PubMed
- 27 citationsGene-expression analysis and the basal-like breast cancer subtypeTimothy J Finnegan, Lisa A. Carey
Future Oncology. 2007-02-05 - 82 citationsRacial Differences in Trust and Regular Source of Patient Care and the Implications for Prostate Cancer Screening UseWilliam R. Carpenter, Paul A. Godley, Jack A. Clark, James A. Talcott, Timothy J Finnegan
Cancer. 2009-11-01
Press Mentions
She Faced Cancer, She Chose JoyApril 2nd, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
